Results
|
|
1.
|
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. [electronic resource] by
- Karachaliou, N
- Ziras, N
- Syrigos, K
- Tryfonidis, K
- Papadimitraki, E
- Kontopodis, E
- Bozionelou, V
- Kalykaki, A
- Georgoulias, V
- Mavroudis, D
Producer: 20120924
In:
Cancer chemotherapy and pharmacology vol. 70
Availability: No items available.
|
|
|
2.
|
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. [electronic resource] by
- Daskalaki, A
- Agelaki, S
- Perraki, M
- Apostolaki, S
- Xenidis, N
- Stathopoulos, E
- Kontopodis, E
- Hatzidaki, D
- Mavroudis, D
- Georgoulias, V
Producer: 20090904
In:
British journal of cancer vol. 101
Availability: No items available.
|
|
|
3.
|
A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer. [electronic resource] by
- Agelaki, S
- Kontopodis, E
- Kotsakis, A
- Chandrinos, V
- Bompolaki, I
- Zafeiriou, Zeta
- Papadimitraki, E
- Stoltidis, D
- Kalbakis, K
- Georgoulias, V
Producer: 20130827
In:
Cancer chemotherapy and pharmacology vol. 72
Availability: No items available.
|
|
|
4.
|
Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). [electronic resource] by
- Katopodis, O
- Souglakos, J
- Stathopoulos, E
- Christopoulou, A
- Kontopodis, E
- Kotsakis, A
- Kalbakis, K
- Kentepozidis, N
- Polyzos, A
- Hatzidaki, D
- Georgoulias, V
Producer: 20141028
In:
Cancer chemotherapy and pharmacology vol. 74
Availability: No items available.
|
|
|
5.
|
Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). [electronic resource] by
- Katsaounis, P
- Kotsakis, A
- Agelaki, S
- Kontopodis, E
- Agelidou, A
- Kentepozidis, N
- Vamvakas, L
- Christopoulou, A
- Karachaliou, N
- Hatzidaki, D
- Georgoulias, V
Producer: 20150526
In:
Cancer chemotherapy and pharmacology vol. 75
Availability: No items available.
|
|
|
6.
|
A nosocomial, foodborne outbreak of Salmonella Enterica serovar Enteritidis in a university hospital in Greece: the importance of establishing HACCP systems in hospital catering. [electronic resource] by
- Gikas, A
- Kritsotakis, E I
- Maraki, S
- Roumbelaki, M
- Babalis, D
- Scoulica, E
- Panoulis, C
- Saloustros, E
- Kontopodis, E
- Samonis, G
- Tselentis, Y
Producer: 20070817
In:
The Journal of hospital infection vol. 66
Availability: No items available.
|
|
|
7.
|
A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer. [electronic resource] by
- Kontopodis, E
- Kotsakis, A
- Kentepozidis, N
- Syrigos, K
- Ziras, N
- Moutsos, M
- Filippa, G
- Mala, A
- Vamvakas, L
- Mavroudis, D
- Georgoulias, V
- Agelaki, S
Producer: 20170206
In:
Cancer chemotherapy and pharmacology vol. 77
Availability: No items available.
|
|
|
8.
|
Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer. [electronic resource] by
- Kontopodis, E
- Kentepozidis, N
- Christophyllakis, Ch
- Boukovinas, I
- Kalykaki, A
- Kalbakis, K
- Vamvakas, L
- Agelaki, S
- Kotsakis, A
- Vardakis, N
- Georgoulias, V
- Mavroudis, D
Producer: 20150303
In:
Cancer chemotherapy and pharmacology vol. 75
Availability: No items available.
|
|
|
9.
|
Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors. [electronic resource] by
- Koinis, F
- Voutsina, A
- Kalikaki, A
- Koutsopoulos, A
- Lagoudaki, E
- Tsakalaki, E
- Dermitzaki, E K
- Kontopodis, E
- Pallis, A G
- Georgoulias, V
- Kotsakis, A
Producer: 20180817
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 20
Availability: No items available.
|
|
|
10.
|
Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy. [electronic resource] by
- Pontikakis, S
- Papadaki, C
- Tzardi, M
- Trypaki, M
- Sfakianaki, M
- Koinis, F
- Lagoudaki, E
- Giannikaki, L
- Kalykaki, A
- Kontopodis, E
- Saridaki, Z
- Malamos, N
- Georgoulias, V
- Souglakos, J
Producer: 20180718
In:
The pharmacogenomics journal vol. 17
Availability: No items available.
|